Cargando…

Hearing Impairment and Neuroimaging Results in Mitochondrial Diseases

Mitochondrial diseases (MDs) are heterogeneous genetic disorders characterized by mitochondrial DNA (mtDNA) defects, involving tissues highly dependent on oxidative metabolism: the inner ear, brain, eye, skeletal muscle, and heart. We describe adult patients with genetically defined MDs, characteriz...

Descripción completa

Detalles Bibliográficos
Autores principales: Cadoni, Gabriella, Primiano, Guido, Picciotti, Pasqualina M., Calandrelli, Rosalinda, Galli, Jacopo, Servidei, Serenella, Conti, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532611/
https://www.ncbi.nlm.nih.gov/pubmed/37763097
http://dx.doi.org/10.3390/jpm13091329
_version_ 1785112001592164352
author Cadoni, Gabriella
Primiano, Guido
Picciotti, Pasqualina M.
Calandrelli, Rosalinda
Galli, Jacopo
Servidei, Serenella
Conti, Guido
author_facet Cadoni, Gabriella
Primiano, Guido
Picciotti, Pasqualina M.
Calandrelli, Rosalinda
Galli, Jacopo
Servidei, Serenella
Conti, Guido
author_sort Cadoni, Gabriella
collection PubMed
description Mitochondrial diseases (MDs) are heterogeneous genetic disorders characterized by mitochondrial DNA (mtDNA) defects, involving tissues highly dependent on oxidative metabolism: the inner ear, brain, eye, skeletal muscle, and heart. We describe adult patients with genetically defined MDs, characterizing hearing function and neuroimaging results. We enrolled 34 patients (mean age: 50.02 ± 15 years, range: 18–75 years; 20 females and 14 males) classified in four groups: MELAS, MIDD, PEO, and Encephalopathy/Polyneuropathy. Audiological evaluations included psychoacoustical tests (pure-tone and speech audiometry), electrophysiological tests (Auditory Brainstem Responses, ABRs), and Impedenzometry. Neuroimaging evaluations considered global MRI abnormalities or structural brain changes. In total, 19/34 patients carried the m.3243A > G mutation (6 affected by MELAS, 12 affected by MIDD, and 1 affected by PEO); 11 had an mtDNA deletion (all affected by PEO); 3 had nuclear genes associated with MDs (POLG1 and OPA1); and 1 patient had an mtDNA deletion without an identified nuclear gene defect (affected by PEO). Sensory neural, bilateral, and symmetrical hearing loss was present in 25 patients (73.5%) to different degrees: 9 mild, 9 moderate, 5 severe, and 2 profound. The severe/profound and mild hearing losses were associated with pantonal and high-frequency audiograms, respectively. Instead, moderate hearing losses were associated with both high-frequency (five cases) and pantonal (five cases) audiogram shapes. In addition, 21/25 patients showed a cochlear site of lesion (84%), and 4/25 (16%) showed a retrocochlear site. We found global MRI abnormalities or structural brain changes in 26/30 subjects (86.6%): 21 had white matter abnormalities, 15 had cortical atrophy, 10 had subcortical atrophy, 8 had basal nuclei involvement or cerebellar atrophy, 4 had stroke-like lesions or laminar necrosis, and 1 had cysts or vacuolated lesions. We concluded that genetic alterations are associated with different clinical presentations for both auditory function and neuroradiological findings. There is no fixed relationship between genotype and phenotype for the clinical conditions analyzed.
format Online
Article
Text
id pubmed-10532611
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105326112023-09-28 Hearing Impairment and Neuroimaging Results in Mitochondrial Diseases Cadoni, Gabriella Primiano, Guido Picciotti, Pasqualina M. Calandrelli, Rosalinda Galli, Jacopo Servidei, Serenella Conti, Guido J Pers Med Article Mitochondrial diseases (MDs) are heterogeneous genetic disorders characterized by mitochondrial DNA (mtDNA) defects, involving tissues highly dependent on oxidative metabolism: the inner ear, brain, eye, skeletal muscle, and heart. We describe adult patients with genetically defined MDs, characterizing hearing function and neuroimaging results. We enrolled 34 patients (mean age: 50.02 ± 15 years, range: 18–75 years; 20 females and 14 males) classified in four groups: MELAS, MIDD, PEO, and Encephalopathy/Polyneuropathy. Audiological evaluations included psychoacoustical tests (pure-tone and speech audiometry), electrophysiological tests (Auditory Brainstem Responses, ABRs), and Impedenzometry. Neuroimaging evaluations considered global MRI abnormalities or structural brain changes. In total, 19/34 patients carried the m.3243A > G mutation (6 affected by MELAS, 12 affected by MIDD, and 1 affected by PEO); 11 had an mtDNA deletion (all affected by PEO); 3 had nuclear genes associated with MDs (POLG1 and OPA1); and 1 patient had an mtDNA deletion without an identified nuclear gene defect (affected by PEO). Sensory neural, bilateral, and symmetrical hearing loss was present in 25 patients (73.5%) to different degrees: 9 mild, 9 moderate, 5 severe, and 2 profound. The severe/profound and mild hearing losses were associated with pantonal and high-frequency audiograms, respectively. Instead, moderate hearing losses were associated with both high-frequency (five cases) and pantonal (five cases) audiogram shapes. In addition, 21/25 patients showed a cochlear site of lesion (84%), and 4/25 (16%) showed a retrocochlear site. We found global MRI abnormalities or structural brain changes in 26/30 subjects (86.6%): 21 had white matter abnormalities, 15 had cortical atrophy, 10 had subcortical atrophy, 8 had basal nuclei involvement or cerebellar atrophy, 4 had stroke-like lesions or laminar necrosis, and 1 had cysts or vacuolated lesions. We concluded that genetic alterations are associated with different clinical presentations for both auditory function and neuroradiological findings. There is no fixed relationship between genotype and phenotype for the clinical conditions analyzed. MDPI 2023-08-29 /pmc/articles/PMC10532611/ /pubmed/37763097 http://dx.doi.org/10.3390/jpm13091329 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cadoni, Gabriella
Primiano, Guido
Picciotti, Pasqualina M.
Calandrelli, Rosalinda
Galli, Jacopo
Servidei, Serenella
Conti, Guido
Hearing Impairment and Neuroimaging Results in Mitochondrial Diseases
title Hearing Impairment and Neuroimaging Results in Mitochondrial Diseases
title_full Hearing Impairment and Neuroimaging Results in Mitochondrial Diseases
title_fullStr Hearing Impairment and Neuroimaging Results in Mitochondrial Diseases
title_full_unstemmed Hearing Impairment and Neuroimaging Results in Mitochondrial Diseases
title_short Hearing Impairment and Neuroimaging Results in Mitochondrial Diseases
title_sort hearing impairment and neuroimaging results in mitochondrial diseases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532611/
https://www.ncbi.nlm.nih.gov/pubmed/37763097
http://dx.doi.org/10.3390/jpm13091329
work_keys_str_mv AT cadonigabriella hearingimpairmentandneuroimagingresultsinmitochondrialdiseases
AT primianoguido hearingimpairmentandneuroimagingresultsinmitochondrialdiseases
AT picciottipasqualinam hearingimpairmentandneuroimagingresultsinmitochondrialdiseases
AT calandrellirosalinda hearingimpairmentandneuroimagingresultsinmitochondrialdiseases
AT gallijacopo hearingimpairmentandneuroimagingresultsinmitochondrialdiseases
AT servideiserenella hearingimpairmentandneuroimagingresultsinmitochondrialdiseases
AT contiguido hearingimpairmentandneuroimagingresultsinmitochondrialdiseases